scholarly journals Cgrp Release and Synergistic Interactions with Nitric Oxide: Implications for Pathogenesis of Septic Shock and the Vascular Problems of Diabetes Mellitus and Aging

2001 ◽  
Vol 1 ◽  
pp. 2-2
Author(s):  
R.R. Fiscus ◽  
X. Wang ◽  
G.H.H. Chan ◽  
A.C.Y. Ma ◽  
S.L. Chan
2018 ◽  
Vol 46 (9) ◽  
pp. e945-e954 ◽  
Author(s):  
Francisco Vasques-Nóvoa ◽  
Tiago L. Laundos ◽  
Rui J. Cerqueira ◽  
Catarina Quina-Rodrigues ◽  
Ricardo Soares-dos-Reis ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-18 ◽  
Author(s):  
Andrea Leiva ◽  
Fabián Pardo ◽  
Marco A. Ramírez ◽  
Marcelo Farías ◽  
Paola Casanello ◽  
...  

Gestational diabetes mellitus (GDM) and obesity in pregnancy (OP) are pathological conditions associated with placenta vascular dysfunction coursing with metabolic changes at the fetoplacental microvascular and macrovascular endothelium. These alterations are seen as abnormal expression and activity of the cationic amino acid transporters and endothelial nitric oxide synthase isoform, that is, the “endothelial L-arginine/nitric oxide signalling pathway.” Several studies suggest that the endogenous nucleoside adenosine along with insulin, and potentially arginases, are factors involved in GDM-, but much less information regards their role in OP-associated placental vascular alterations. There is convincing evidence that GDM and OP prone placental endothelium to an “altered metabolic state” leading to fetal programming evidenced at birth, a phenomenon associated with future development of chronic diseases. In this paper it is suggested that this pathological state could be considered as a metabolic marker that could predict occurrence of diseases in adulthood, such as cardiovascular disease, obesity, diabetes mellitus (including gestational diabetes), and metabolic syndrome.


Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Timea Beleznai ◽  
Attila Feher ◽  
Ibolya Rutkai ◽  
Istvan Edes ◽  
Zsolt Bagi

Hyperglycemia is associated with serious microvascular complications in diabetes mellitus. We hypothesized that under high glucose concentrations, activation of the hexosamine pathway leads to protein O-linked-N-acetylglucosamine (O-GlcNAc) formation which interferes with nitric oxide (NO)-dependent arteriolar dilation. Thus, diameter changes of skeletal muscle arterioles (diameter: ~ 160 μm) isolated from healthy, male Wistar rats were investigated after exposure to normal glucose (NG, 5.5 mM) or high glucose (HG, 30 mM for 2 hours) concentrations. In arterioles exposed to HG concentration, dilations to histamine were markedly reduced compared to those of under NG condition (max: −6±6% and 69±9%, respectively). Inhibition of NO synthesis with L-NAME reduced histamine-induced dilations in NG arterioles, but it had no effect on microvessels exposed to HG. Dilations to the NO donor, sodium nitroprusside were similar in the two groups of vessels. In the presence of the inhibitor of hexosamine pathway, azaserine histamine-induced dilations were significantly augmented and diminished by additional administration of L-NAME in arterioles exposed to HG concentrations (max: 67±2%). Moreover, under NG condition, exposure of vessels to glucosamine (5 mM, for 2 hours) resulted in reduced histamine-induced arteriolar dilations (max: 26±3%). Upon HG and glucosamine treatment an enhanced O-GlcNAc formation of endothelial NO synthase (eNOS) was detected by Western blots and immunoprecipitation. These findings indicate that high glucose concentration may lead to O-GlcNAc formation of eNOS, which impairs histamine-induced, NO-mediated arteriolar dilations. We propose that interfering with the hexosamine pathway may prevent microvascular complications in diabetes mellitus. On the other hand, our data suggest caveat for glucosamine supplementation to treat osteoarthritis, since it may impair microvascular function.


1996 ◽  
Vol 271 (4) ◽  
pp. C1098-C1102 ◽  
Author(s):  
A. Sjoholm

Preceding the onset of insulin-dependent diabetes mellitus, pancreatic islets are infiltrated by macrophages secreting interleukin-1 beta, which exerts cytotoxic and inhibitory actions on islet beta-cell insulin secretion through induction of nitric oxide (NO) synthesis. The influence of the NO donor 3-morpholinosydnonimine (SIN-1) on insulin secretion from isolated pancreatic islets in response to various secretagogues was investigated. Stimulation of insulin release evoked by glucose, phospholipase C activation with carbachol, and protein kinase C activation with phorbol ester were obtained by SIN-1, whereas the response to adenylyl cyclase activation or K(+)-induced depolarization was not affected. It is concluded that enzymes involved in glucose catabolism, phospholipase C or protein kinase C, may be targeted by NO. Reversal of SIN-1 inhibition of glucose-stimulated insulin release by dithiothreitol suggests that NO may inhibit insulin secretion partly by S-nitrosylation of thiol residues in key proteins in the stimulus-secretion coupling. These adverse effects of NO on the beta-cell stimulus-secretion coupling may be of importance for the development of the impaired insulin secretion characterizing diabetes mellitus.


The Lancet ◽  
1991 ◽  
Vol 338 (8782-8783) ◽  
pp. 1555-1557 ◽  
Author(s):  
E. Nava ◽  
R.M.J. Palmer ◽  
S. Moncada

Sign in / Sign up

Export Citation Format

Share Document